| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/IJD.13580 |
| P698 | PubMed publication ID | 28321838 |
| P2093 | author name string | Robert A Schwartz | |
| Marc Z Handler | |||
| Nancy S Handler | |||
| Glenn A Handler | |||
| Matthew P Stephany | |||
| P2860 | cites work | A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis | Q24310146 |
| A gene outside the human MHC related to classical HLA class I genes | Q24320252 | ||
| Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C | Q24647490 | ||
| The "insanity" of King George 3d: a classic case of porphyria | Q24672224 | ||
| A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda | Q24681370 | ||
| Cutaneous manifestations of hepatitis C in the era of new antiviral agents | Q26773669 | ||
| Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria | Q28272057 | ||
| A mouse model of familial porphyria cutanea tarda | Q28507743 | ||
| King George III and porphyria: an elemental hypothesis and investigation | Q30858045 | ||
| The role of iron in the pathophysiology and treatment of chronic hepatitis C. | Q33586881 | ||
| Porphyria cutanea tarda and HIV/AIDS: a review of pathogenesis, clinical manifestations and management | Q33601204 | ||
| Porphyria cutanea tarda and Sjogren's syndrome | Q34104921 | ||
| Pseudoporphyria | Q34124698 | ||
| The Molecular Basis of the Action of Chloroquine in Porphyria Cutanea Tarda | Q34217909 | ||
| Pseudoporphyria: a clinical and biochemical study of 20 patients | Q34253868 | ||
| Hepatitis C, porphyria cutanea tarda and liver iron: an update | Q34268811 | ||
| Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda | Q34300246 | ||
| The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase | Q34481669 | ||
| Pseudoporphyria: an atypical variant resembling toxic epidermal necrolysis | Q34573251 | ||
| Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives | Q34979462 | ||
| Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. | Q35217843 | ||
| Association of porphyria cutanea tarda with hereditary hemochromatosis | Q35849167 | ||
| Genetic aspects of porphyria cutanea tarda. | Q36733958 | ||
| Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials | Q36936862 | ||
| Hemochromatosis: an endocrine liver disease. | Q36948509 | ||
| Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer. | Q36962305 | ||
| Down-regulation of hepcidin in porphyria cutanea tarda | Q37002005 | ||
| Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron | Q37291741 | ||
| Pseudoporphyria induced by hemodialysis. | Q37634333 | ||
| Structure and function of enzymes in heme biosynthesis. | Q37761084 | ||
| Porphyria cutanea tarda – When skin meets liver | Q37801101 | ||
| A review of UVA-mediated photosensitivity disorders | Q37962812 | ||
| Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology | Q38164825 | ||
| Effects of iron overload on chronic metabolic diseases. | Q38204538 | ||
| Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes | Q38208296 | ||
| Skin diseases associated with Agent Orange and other organochlorine exposures. | Q38554124 | ||
| Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association? | Q40520697 | ||
| Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital. | Q40906715 | ||
| Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients | Q41718961 | ||
| Hepatitis C- and HIV-induced porphyria cutanea tarda | Q41890505 | ||
| Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda | Q41916262 | ||
| Porphyria cutanea tarda and systemic lupus erythematosus | Q41933200 | ||
| Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload | Q41935315 | ||
| Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells | Q42198736 | ||
| Pseudoporphyria cutanea tarda induced by furosemide in a patient undergoing peritoneal dialysis | Q42538348 | ||
| Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america† | Q42988426 | ||
| Skin diseases associated with hepatitis C virus: facts and controversies. | Q42999441 | ||
| Porphyria cutanea tarda and antibodies to hepatitis C virus. | Q43038650 | ||
| Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients. | Q43047755 | ||
| Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription | Q43047877 | ||
| Porphyria cutanea tarda induced by olmesartan. | Q43218719 | ||
| Spectrophotometric quantification of total urinary porphyrins as a screening test for porphyrias: threshold value revisited | Q43677669 | ||
| Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies | Q43862006 | ||
| The association between porphyria cutanea tarda and diabetes mellitus: analysis of a long-term follow-up cohort | Q44143427 | ||
| Porphyrias in Norway. | Q44408184 | ||
| Comparison of two assay methods for activities of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase | Q44411132 | ||
| Ciguatera in Puerto Rico and the Virgin Islands. | Q45945361 | ||
| Familial porphyria cutanea tarda in Spain: Characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation | Q45954724 | ||
| Chlorinated biphenyls induce cytochrome P450IA2 and uroporphyrin accumulation in cultures of mouse hepatocytes | Q54317196 | ||
| Suppression of Erythropoiesis by Alcohol | Q55619804 | ||
| Acquired Porphyria in Man and Rat due to Hexachlorobenzene Intoxication | Q59063889 | ||
| P433 | issue | 6 | |
| P921 | main subject | porphyria cutanea tarda | Q1479497 |
| P304 | page(s) | e106-e117 | |
| P577 | publication date | 2017-03-21 | |
| P1433 | published in | International Journal of Dermatology | Q15752742 |
| P1476 | title | Porphyria cutanea tarda: an intriguing genetic disease and marker | |
| P478 | volume | 56 |
Search more.